Up a level |
Singh, Dave, Wedzicha, Jadwiga A, Siddiqui, Salman, de la Hoz, Alberto, Xue, Wenqiong, Magnussen, Helgo, Miravitlles, Marc, Chalmers, James D and Calverley, Peter MA
(2020)
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
RESPIRATORY RESEARCH, 21 (1).
240-.
Wilkinson, Maxim, Maidstone, Robert, Loudon, Andrew, Blaikley, John, White, Iain R, Singh, Dave, Ray, David W, Goodacre, Royston ORCID: 0000-0003-2230-645X, Fowler, Stephen J and Durrington, Hannah J
(2019)
Circadian rhythm of exhaled biomarkers in health and asthma.
EUROPEAN RESPIRATORY JOURNAL, 54 (4).
1901068-.
van Haren, Frank MP, Page, Clive, Laffey, John G, Artigas, Antonio, Camprubi-Rimblas, Marta, Nunes, Quentin ORCID: 0000-0002-7513-8595, Smith, Roger, Shute, Janis, Carroll, Mary, Tree, Julia et al (show 4 more authors)
(2020)
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
CRITICAL CARE, 24 (1).
454-.
Mathioudakis, Alexander G, Fally, Markus, Hashad, Rola, Kouta, Ahmed, Hadi, Ali Sina, Knight, Sean Blandin, Bakerly, Nawar Diar, Singh, Dave, Williamson, Paula R ORCID: 0000-0001-9802-6636, Felton, Tim et al (show 1 more authors)
(2020)
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review.
LIFE-BASEL, 10 (12).
E350-.
Wedzicha, Jadwiga A, Buhl, Roland, Singh, Dave, Vogelmeier, Claus F, de la Hoz, Alberto, Xue, Wenqiong, Anzueto, Antonio and Calverley, Peter MA
(2020)
Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials.
Advances in Therapy, 37 (8).
pp. 4266-4279.
Tree, Julia A, Turnbull, Jeremy E ORCID: 0000-0002-1791-754X, Buttigieg, Karen R, Elmore, Michael J, Coombes, Naomi, Hogwood, John, Mycroft-West, Courtney J, Lima, Marcelo A, Skidmore, Mark A, Karlsson, Richard et al (show 10 more authors)
(2021)
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
BRITISH JOURNAL OF PHARMACOLOGY, 178 (3).
pp. 626-635.